Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Details:
KBro-Vet-CA1 meets the criteria of conditional approval under the expanded authority, as there is currently no animal drug approved and marketed in the U.S. for the treatment of idiopathic epilepsy in dogs.
Lead Product(s): Potassium Bromide
Therapeutic Area: Neurology Product Name: KBroVet-CA1
Highest Development Status: ApprovedProduct Type: Small molecule
Partner/Sponsor/Collaborator: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable January 14, 2021